|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.35 USD | -0.15% |
|
+1.02% | -13.99% |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 11.39B | 12.46B | 12.11B | 11.92B | 12.11B | |||||
Total Revenues | 11.39B | 12.46B | 12.11B | 11.92B | 12.11B | |||||
Cost of Goods Sold, Total | 9.42B | 10.29B | 10.11B | 9.89B | 10.2B | |||||
Gross Profit | 1.96B | 2.16B | 2B | 2.03B | 1.9B | |||||
Selling General & Admin Expenses, Total | 789M | 845M | 908M | 893M | 905M | |||||
R&D Expenses | 33.6M | 34.7M | 33.7M | 36.1M | 35.2M | |||||
Other Operating Expenses, Total | 823M | 879M | 942M | 929M | 941M | |||||
Operating Income | 1.14B | 1.29B | 1.06B | 1.1B | 961M | |||||
Interest Expense, Total | -43.31M | -62.52M | -73.4M | -80.89M | -78.04M | |||||
Interest And Investment Income | 46.88M | 28.01M | 14.83M | 48.4M | 24.23M | |||||
Net Interest Expenses | 3.57M | -34.5M | -58.57M | -32.5M | -53.81M | |||||
Income (Loss) On Equity Invest. | 47.76M | 27.18M | 42.75M | 51.09M | -106M | |||||
Other Non Operating Income (Expenses) | 0 | - | 0 | - | 11.35M | |||||
EBT, Excl. Unusual Items | 1.19B | 1.28B | 1.04B | 1.12B | 812M | |||||
Restructuring Charges | - | - | - | -53.01M | -77.6M | |||||
Merger & Related Restructuring Charges | -43.2M | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | -11.32M | |||||
Asset Writedown | - | - | -28.38M | - | -70.75M | |||||
Legal Settlements | - | - | - | -28.75M | 10.76M | |||||
Other Unusual Items | -21M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 1.13B | 1.28B | 1.01B | 1.04B | 663M | |||||
Income Tax Expense | 217M | 278M | 221M | 231M | 186M | |||||
Earnings From Continuing Operations | 909M | 1B | 793M | 805M | 478M | |||||
Net Income to Company | 909M | 1B | 793M | 805M | 478M | |||||
Minority Interest | -301K | -239K | 653K | 407K | 433K | |||||
Net Income - (IS) | 909M | 1B | 794M | 805M | 478M | |||||
Net Income to Common Incl Extra Items | 909M | 1B | 794M | 805M | 478M | |||||
Net Income to Common Excl. Extra Items | 909M | 1B | 794M | 805M | 478M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.68 | 1.84 | 1.45 | 1.47 | 0.87 | |||||
Basic EPS - Continuing Operations | 1.68 | 1.84 | 1.45 | 1.47 | 0.87 | |||||
Basic Weighted Average Shares Outstanding | 541M | 545M | 546M | 548M | 550M | |||||
Net EPS - Diluted | 1.66 | 1.82 | 1.45 | 1.47 | 0.87 | |||||
Diluted EPS - Continuing Operations | 1.66 | 1.82 | 1.45 | 1.47 | 0.87 | |||||
Diluted Weighted Average Shares Outstanding | 548M | 550M | 549M | 549M | 550M | |||||
Normalized Basic EPS | 1.37 | 1.47 | 1.19 | 1.27 | 0.92 | |||||
Normalized Diluted EPS | 1.36 | 1.45 | 1.19 | 1.27 | 0.92 | |||||
Dividend Per Share | 0.98 | 1.04 | 1.1 | 1.13 | 1.16 | |||||
Payout Ratio | 57.56 | 55.78 | 74.72 | 76.39 | 132.41 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.37B | 1.55B | 1.31B | 1.36B | 1.22B | |||||
EBITA | 1.18B | 1.34B | 1.08B | 1.12B | 983M | |||||
EBIT | 1.14B | 1.29B | 1.06B | 1.1B | 961M | |||||
EBITDAR | 1.93B | 2.04B | 1.86B | 1.79B | 1.63B | |||||
Effective Tax Rate - (Ratio) | 19.27 | 21.74 | 21.76 | 22.29 | 27.99 | |||||
Current Domestic Taxes | 179M | 87.69M | 181M | 128M | 115M | |||||
Current Foreign Taxes | 9.08M | 13.18M | 7.58M | 15.2M | 17.68M | |||||
Total Current Taxes | 188M | 101M | 189M | 143M | 133M | |||||
Deferred Domestic Taxes | 25.73M | 178M | 31.82M | 89.33M | 54.51M | |||||
Deferred Foreign Taxes | 2.95M | -729K | -29K | -1.66M | -1.64M | |||||
Total Deferred Taxes | 28.68M | 177M | 31.79M | 87.67M | 52.87M | |||||
Normalized Net Income | 744M | 799M | 652M | 699M | 508M | |||||
Interest on Long-Term Debt | 43.31M | 62.52M | 73.4M | 80.89M | 78.04M | |||||
Non-Cash Pension Expense | -31.05M | -46.66M | 1.81M | 8.22M | 9.66M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 138M | 157M | 160M | 163M | 148M | |||||
Selling and Marketing Expenses | 138M | 157M | 160M | 163M | 148M | |||||
Research And Development Expense From Footnotes | 33.6M | 34.7M | 33.7M | 36.1M | 35.2M | |||||
Net Rental Expense, Total | 567M | 489M | 546M | 432M | 403M | |||||
Imputed Operating Lease Interest Expense | 82.52M | 72.21M | 94.03M | 86.64M | 83.43M | |||||
Imputed Operating Lease Depreciation | 484M | 417M | 452M | 346M | 320M | |||||
Stock-Based Comp., Other (Total) | 24.74M | 24.94M | 24.08M | 23.23M | 25.6M | |||||
Total Stock-Based Compensation | 24.74M | 24.94M | 24.08M | 23.23M | 25.6M |
- Stock Market
- Equities
- HRL Stock
- Financials Hormel Foods Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















